Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
16 Apr 2024
// Amber Tong ENDPTS
https://endpts.com/astellas-books-450m-writedown-on-preclinical-gene-therapy-anemia-drug/
21 Jan 2023
// Nick Paul Taylor FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/astellas-after-years-gene-therapy-woes-gets-rare-boost-fda-lifting-pompe-clinical-hold#:~:text=The%20FDA%20has%20handed%20a,participant%20developed%20peripheral%20sensory%20neuropathy
28 Apr 2021
// Ben Adams FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/astellas-takes-540m-impairment-charge-over-audentes-gene-therapy-trial-hold
02 Apr 2021
// Marta Figueiredo PhD MUSCULARDYSTROPHYNEWS
https://musculardystrophynews.com/2021/04/06/audentes-becomes-astellas-gene-therapies-will-advance-treatments-for-muscular-dystrophy-md-other-conditions/
01 Jan 2021
// Ned Pagliarulo BIOPHARMADIVE
https://www.biopharmadive.com/news/astellas-gene-therapy-audentes-holles-depart/597703/
31 Dec 2020
// Ben Adams FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/takeda-audentes-see-fda-hold-lifted-after-three-trial-deaths-blighted-3b-program
ABOUT THIS PAGE